HealthCor Management L P's Q3 2021 13F: 20 new positions, 17 exits
Form 13F-HR for the quarter ended Sep 30, 2021 · filed Nov 15, 2021 · 72 reported positions · accession 0001343781-21-000007
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| Increased | BRISTOL-MYERS SQUIBB CO (BMY) | 4.0% | 9.2% | +5.2 pts | +2.11M sh | +143% |
| Exited | REGENERON PHARMACEUTICALS (REGN) | 4.4% | — | −4.4 pts | −190K sh | −100% |
| Exited | HUMANA INC (HUM) | 4.3% | — | −4.3 pts | −239K sh | −100% |
| Exited | DANAHER CORPORATION (DHR) | 4.2% | — | −4.2 pts | −385K sh | −100% |
| Reduced | CVS HEALTH CORP (CVS) | 4.3% | 0.6% | −3.7 pts | −1.09M sh | −86% |
| Exited | THERMO FISHER SCIENTIFIC INC (TMO) | 3.8% | — | −3.8 pts | −183K sh | −100% |
| Increased | AMERISOURCEBERGEN CORP (COR) | 1.2% | 4.7% | +3.4 pts | +632K sh | +239% |
| Reduced | ENCOMPASS HEALTH CORP (EHC) | 3.4% | 0.4% | −3.0 pts | −936K sh | −89% |
| Reduced | ZIMMER BIOMET HOLDINGS INC (ZBH) | 5.0% | 2.1% | −2.9 pts | −434K sh | −57% |
| New | CENTENE CORP DEL (CNC) | — | 2.7% | +2.7 pts | +983K sh | new |
| New | JAZZ PHARMACEUTICALS PLC (JAZZ) | — | 2.6% | +2.6 pts | +461K sh | new |
| Increased | MCKESSON CORP (MCK) | 1.3% | 3.8% | +2.6 pts | +282K sh | +175% |
| Reduced | MARAVAI LIFESCIENCES HLDGS I (MRVI) | 2.2% | 0.5% | −1.6 pts | −1.01M sh | −80% |
| Reduced | ALIGN TECHNOLOGY INC (ALGN) | 3.0% | 1.4% | −1.6 pts | −72,050 sh | −61% |
| Increased | TENET HEALTHCARE CORP (THC) | 1.0% | 3.1% | +2.1 pts | +708K sh | +188% |
| Increased | ENVISTA HOLDINGS CORPORATION (NVST) | 2.1% | 4.1% | +2.0 pts | +1.08M sh | +93% |
| New | CIGNA CORP NEW (CI) | — | 1.8% | +1.8 pts | +212K sh | new |
| Increased | LIVANOVA PLC (LIVN) | 0.4% | 2.2% | +1.8 pts | +527K sh | +422% |
| Exited | VEEVA SYS INC (VEEV) | 1.7% | — | −1.7 pts | −136K sh | −100% |
| Exited | AMGEN INC (AMGN) | 1.6% | — | −1.6 pts | −158K sh | −100% |
| Increased | BIOGEN INC (BIIB) | 4.8% | 5.7% | +0.9 pts | +128K sh | +38% |
| New | CANO HEALTH INC (CANO) | — | 1.5% | +1.5 pts | +2.75M sh | new |
| New | BECTON DICKINSON & CO (BDX) | — | 1.5% | +1.5 pts | +141K sh | new |
| Reduced | ZOETIS INC (ZTS) | 1.8% | 0.7% | −1.1 pts | −146K sh | −64% |
| Increased | BOSTON SCIENTIFIC CORP (BSX) | 2.1% | 3.2% | +1.1 pts | +497K sh | +41% |
| Exited | DEXCOM INC (DXCM) | 0.9% | — | −0.9 pts | −50,890 sh | −100% |
| Increased | NEVRO CORP (NVRO) | 2.6% | 2.7% | +0.1 pts | +153K sh | +41% |
| Increased | HCA HEALTHCARE INC (HCA) | 1.4% | 2.5% | +1.1 pts | +67,650 sh | +40% |
| Increased | WELLTOWER INC (WELL) | 1.5% | 2.2% | +0.7 pts | +183K sh | +42% |
| Reduced | STRYKER CORPORATION (SYK) | 2.9% | 2.6% | −0.4 pts | −50,680 sh | −19% |
| Increased | VENTAS INC (VTR) | 1.1% | 1.7% | +0.6 pts | +235K sh | +48% |
| Exited | ARYA SCIENCES ACQU CORP IV (ARYD) | 0.5% | — | −0.5 pts | −1.24M sh | −100% |
| Increased | NATERA INC (NTRA) | 3.7% | 4.4% | +0.7 pts | +108K sh | +14% |
| Reduced | CYTOKINETICS INC (CYTK) | 0.6% | 0.7% | +0.1 pts | −315K sh | −42% |
| Reduced | SYNDAX PHARMACEUTICALS INC (SNDX) | 1.2% | 1.0% | −0.2 pts | −537K sh | −31% |
| Increased | BIOHAVEN PHARMACTL HLDG CO L (BHVN) | 0.0% | 0.5% | +0.5 pts | +71,183 sh | +647% |
| Increased | BIOCRYST PHARMACEUTICALS INC (BCRX) | 2.1% | 2.4% | +0.3 pts | +601K sh | +19% |
| New | FATE THERAPEUTICS INC (FATE) | — | 0.3% | +0.3 pts | +128K sh | new |
| New | BIONTECH SE (BNTX) | — | 0.3% | +0.3 pts | +23,690 sh | new |
| Exited | IRONWOOD PHARMACEUTICALS INC (IRWD) | 0.3% | — | −0.3 pts | −523K sh | −100% |
| Reduced | HALOZYME THERAPEUTICS INC (HALO) | 1.2% | 0.9% | −0.3 pts | −156K sh | −24% |
| Increased | NEUROCRINE BIOSCIENCES INC (NBIX) | 1.6% | 1.9% | +0.3 pts | +55,759 sh | +14% |
| New | INCYTE CORP (INCY) | — | 0.2% | +0.2 pts | +75,000 sh | new |
| New | ARYA SCIENCES ACQUISITN CORP (ARYE) | — | 0.2% | +0.2 pts | +500K sh | new |
| Exited | CM LIFE SCIENCES III INC (CMLT) | 0.2% | — | −0.2 pts | −500K sh | −100% |
| New | LEAP THERAPEUTICS INC (LPTX) | — | 0.2% | +0.2 pts | +1.2M sh | new |
| Increased | HORIZON THERAPEUTICS PUB L (HZNP) | 4.7% | 6.1% | +1.3 pts | +43,180 sh | +3% |
| Increased | IDEXX LABS INC (IDXX) | 0.8% | 1.0% | +0.2 pts | +5,900 sh | +20% |
| Increased | UNIVERSAL HLTH SVCS INC (UHS) | 2.0% | 2.1% | +0.1 pts | +23,103 sh | +7% |
| Exited | GALAPAGOS NV (LKFT) | 0.1% | — | −0.1 pts | −41,080 sh | −100% |
The 50 largest of 75 changes, by size of the trade. Full holdings for this quarter.
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 49.1% of the equity book
Changes in the top 10 this quarter: COR entered · NTRA entered · NVST entered · MCK entered · MDT entered · BSX entered · ZBH left · REGN left · HUM left · CVS left · DHR left · TMO left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | BRISTOL-MYERS SQUIBB CO (BMY) | 4.0% | 9.2% | |
| 2 | HORIZON THERAPEUTICS PUB L (HZNP) | 4.7% | 6.1% | |
| 3 | BIOGEN INC (BIIB) | 4.8% | 5.7% | |
| 4 | AMERISOURCEBERGEN CORP (COR) | 1.2% | 4.7% | Entered the top 10 |
| 5 | PETCO HEALTH & WELLNESS CO I (WOOF) | 4.5% | 4.5% | |
| 6 | NATERA INC (NTRA) | 3.7% | 4.4% | Entered the top 10 |
| 7 | ENVISTA HOLDINGS CORPORATION (NVST) | 2.1% | 4.1% | Entered the top 10 |
| 8 | MCKESSON CORP (MCK) | 1.3% | 3.8% | Entered the top 10 |
| 9 | MEDTRONIC PLC (MDT) | 3.1% | 3.3% | Entered the top 10 |
| 10 | BOSTON SCIENTIFIC CORP (BSX) | 2.1% | 3.2% | Entered the top 10 |
| — | ZIMMER BIOMET HOLDINGS INC (ZBH) | 5.0% | 2.1% | Left the top 10 |
| — | REGENERON PHARMACEUTICALS (REGN) | 4.4% | 0.0% | Left the top 10 |
| — | HUMANA INC (HUM) | 4.3% | 0.0% | Left the top 10 |
| — | CVS HEALTH CORP (CVS) | 4.3% | 0.6% | Left the top 10 |
| — | DANAHER CORPORATION (DHR) | 4.2% | 0.0% | Left the top 10 |
| — | THERMO FISHER SCIENTIFIC INC (TMO) | 3.8% | 0.0% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).
Option positions (puts and calls)
Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.
| Activity | Security | Type | Shares before | Shares now | Reported value |
|---|---|---|---|---|---|
| Exited | VERTEX PHARMACEUTICALS INC (VRTX) | Call | 187K | 0 | $0 |
| Exited | NOVAVAX INC (NVAX) | Put | 23,500 | 0 | $0 |